Different mechanisms for inhibition of cell proliferation via cell cycle proteins in PC12 cells by nerve growth factor and staurosporine

Journal of Neuroscience Research

Volumn 49, Issue 4, 1997, Pages 461-474

  Gollapudi, L ^a   Neet, K E ^a,b  

^a The Chicago Medical College   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Cyclin; Differentiation; Kinase; Mitogenesis; Signal pathway

Indexed keywords

NERVE GROWTH FACTOR; STAUROSPORINE;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL PROLIFERATION; DNA REPLICATION; GROWTH REGULATION; NERVE CELL DIFFERENTIATION; NERVE GROWTH; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BLOTTING, WESTERN; CDC2 PROTEIN KINASE; CDC2-CDC28 KINASES; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; CULTURE MEDIA; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASES; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; NERVE GROWTH FACTORS; PC12 CELLS; PROTEIN-SERINE-THREONINE KINASES; RATS; SIGNAL TRANSDUCTION; STAUROSPORINE; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030747261     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19970815)49:4<461::AID-JNR7>3.0.CO;2-6     Document Type: Article

References (83)

1. Aloni-Grinstein R, Zan-Bar I, Alboum I, Goldfinger N, Rotter V (1993): Wild type p53 functions as a control protein in the differentiation pathway of the B-cell lineage. Oncogene 8:3297-3305.
2. Amon A, Tyers M, Futcher B, Nasmyth K (1993): Mechanisms that help the yeast cell cycle clock tick: G2 cyclins transcriptionally activate G2 cyclins and repress G1 cyclins. Cell 74:993-1007.
3. Batistatou A, Greene LA (1993): Internucleosomal DNA cleavage and neuronal cell survival/death. J Cell Biol 122:523-532.
4. Baudier J, Delphin C, Grunwald D, Khochbin S, Lawrence JJ (1992): Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and a S100b-binding protein. Proc Natl Acad Sci USA 89:11627-11631.
5. Bischoff JR, Friedman PN, Marshak DR, Prives C, Beach D (1990): Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2. Proc Natl Acad Sci USA 87:4766-4770.
6. Buchkovich K, Ziff E (1994): NGF regulates the expression and activity of p33cdk2 and p34cdc2 kinases in PC 12 pheochromocytoma cells. Molec Biol Cell 5:1225-1241.
7. Campbell XZ, Neet KE (1995): Hierarchial analysis of the NGF dependent and NGF-independent differentiation signalling pathways in PC 12 cells with protein kinase inhibitors. J Neurosci Res 42:207-219.
8. Crissman HA, Gadbois DM, Tobey RA, Bradbury EM (1991): Transformed mammalian cells are deficient in kinase-mediated control of progression through the G1 phase of the cell cycle. Proc Natl Acad Sci USA 88:7580-7584.
9. Decker SJ (1995): Nerve growth factor-induced growth arrest and induction of p21Cip1/WAF1 in NIH-3T3 cells expressing TrkA. J Biol Chem 270:30841-30844.
10. Donehower LA, Bradley A (1993): The tumor suppressor protein p53. Biochim Biophys Acta 1155:181-205.
11. Eizenberg O, Faber-Elman A, Gottlieb E, Oren M, Rotter V, Schwartz M (1996): p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells. Mol Cell Biol 16:5178-5185.
12. El-Diery WS, Tokino T, Velculescu VE, Levy D, Parsons R, Trent J, Lin D, Mercer E, Kinzler K, Vogelstein B (1993): WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
13. Feinstein E, Gale RP (1992): Expression of the normal p53 gene induces differentiation of K562 cells. Oncogene 7:1853-1857.
14. Fields A, Pincus S, Kraft A, May WS (1989): Phosphorylation of lamin B at the nuclear membrane by activated protein kinase C. J Biol Chem 263:8253-8260.
15. Fisher RP, Morgan DO (1994): A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell 78:713-724.
16. Freeman R, Donoghue D (1991): Protein kinases and protooncogenes: Biochemical regulators of the eucaryotic cell cycle. Biochemistry 30:2293-2302.
17. Freeman RS, Estus S, Johnson E (1994): Analysis of cell cycle related gene expression in post mitotic neurons: Selective induction of cyclin D1 during programmed cell death. Neuron 12:343-355.
18. Furukawa K, Onodera H, Kogure K, Akaike N (1993): Time-dependent expression of Na and Ca channels in PC 12 cells by nerve growth factor and cAMP. Neurosci Res 16:143-147.
19. Gadbois D, Hamaguchi J, Swank R, Bradbury M (1992): Staurosporine is a potent inhibitor of p34cdc2 and p34cdc2-like kinases. Biochem Biophys Res Comm 184:80-85.
20. Gadbois DM, Peterson S, Bradbury EM, Lehnert BE (1995): CDK4/ Cyclin D1/PCNA complexes during staurosporine-induced G1 arrest and GO Arrest of human fibroblasts. Exp Cell Res 220:220-225.
21. Gannon JV, Greaves JV, Iggo R, Lane DP (1990): Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J 9:1595-1602.
22. Gollapudi, L. Nerve Growth Factor Control of Cell Cycle in PC12 Cells. PhD Dissertation, Finch UHS/CMS, 1995.
23. Greene L, Tischler AS (1976): Establishment of a non-adrenergic clonal cell line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 73:2424-2428.
24. Greene LA (1978): Nerve growth factor prevents the death and stimulates the neuronal differentiation of clonal PC12 pheochromocytoma cells in serum-free medium. J Cell Biol 78:747-755.
25. Gunning PW, Landreth GE, Bothwell MA, Shooter EM (1981a): Differential and synergistic actions of nerve growth factor and cyclic AMP in PC12 cells. J Cell Biol 89:240-245.
26. Gunning PW, Landreth GE, Layer P, Ignatius M, Shooter EM (1981b): Nerve growth factor induced differentiation of PC12 cells: Evaluation of changes in RNA and DNA metabolism. J Neurosci 1:368-379.
27. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D, Lassar AB (1995): Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018-1021.
28. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ (1993): The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
29. Hashimoto S, Hagino A (1989a): Staurosporine induced neurite outgrowth in PC12h cells. Exp Cell Res 184:351-359.
30. Hashimoto S, Hagino A (1989b): Blockage of NGF action in PC12 cells by staurosporine a potent protein kinase inhibitor. J Neurochem 53:1675-1685.
31. Herbert J, Seban E, Maffrand J (1990): Characterisation of specific binding sites for [3H]-staurosporine on various protein kinases. Biochem Biophys Res Comm 171:189-195.
32. Hunter T, Pines J (1994): Cyclins and cancer II: Cyclin D and CDK inhibitors come of age. Cell 79:573-582.
33. Ignatius MJ, Chandler CR, Shooter EM (1985): Nerve growth factor treated neurite bearing PC12 cells continue to synthesize DNA. J Neurosci 5:343-351.
34. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW (1991a): Participation of p53 in the cellular response to DNA damage. Cancer Res 51:6304-6311.
35. Kastan MB, Radin AI, Kuerbitz SJ, Craig RW (1991b): Levels of p53 protein increase with maturation in human hematopoietic cells. Cancer Res 51:4279-4286.
36. Knippschild U, Oren M, Deppert W (1996): Abrogation of wild-type p53 mediated growth-inhibition by nuclear exclusion. Oncogene 12:1755-1765.
37. Knusel B, Hefti F (1992): K-252 compounds: Modulators of neurotrophin signal transduction. J Neurochem 59:1987-1996.
38. Lin D, Shields MT, Ullrich SJ, Apella E, Mercer WE (1992): Growth arrest induced by wild type p53 protein blocks cells prior to near the restriction point in late G1 phase. Proc Natl Acad Sci USA 89:9210-9214.
39. Lin W, Desidereo S (1993): Regulation of V(D)J recombination activator protein Rag-2 by phosphorylation. Science 260:953-959.
40. Mailer J, Gautier J, Langan T, Shenoy S, Shalloway D, Nurse P (1989): Maturation promoting factor and the regulation of the cell cycle. J Cell Sci 12:53-63.
41. Mark MD, Liu Y, Wong ST, Hinds TR, Storm DR (1995): Stimulation of neurite outgrowth in PC12 cells by EGF and KC1 depolarization: A Ca(2+)-independent phenomenon. J Cell Biol 130:701-710.
42. Martinez J, Georgoff I, Levine AJ (1991): Cellular localization and cell cycle regulation by a temperature sensitive p53 protein. Genes Dev 5:151-159.
43. Matsushime H, Ewen M, Strom D, Kalo J, Handks S, Roussel M, Sherr C (1992): Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell 71:323-334.
44. Mercer WE, Shields MT, Ullrich SJ (1990): Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild type p53. Proc Natl Acad Sci USA 87:6166-6170.
45. Michalovitz D, Halevy O, Oren M (1990): Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62:671-680.
46. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D (1994): Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 54:3391-3395.
47. Milner J, Cook A, Mason J (1990): p53 is associated with p34cdc2 in transformed cells. EMBO J 9:2885-2889.
48. Morgan DO (1995): Principles of CDK regulation. Nature 374:131-134.
49. Nye S, Squinto S, Glass D, Stitt T, Hantzopoulos P, Macchi M, Lindsay N, Ip N, Yancopoulos G (1992): K-252a and staurosporine selectively block autophosphorylation of neurotrophin receptors and neurotrophin-mediated responses. Mol Biol Cell 3:1-10.
50. Okamato K, Beach D (1994): Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J 13:4816-4822.
51. Parker SB, Eichele G, Zhang P, Rawls A, Sands AT, Bradley A, Olson EN, Harper JW, Elledge SJ (1995): p53-independent expression of p21/Cip1 in muscle and other terminally differentiating cells. Science 267:1024-1028.
52. Pavlovic-Surjancev B, Cahill AL, Perlman RL (1993): Staurosporine activates a 60,000 M(r) protein kinase in bovine chromaffin cells that phosphorylates myelin basic protein in vitro. J Neurochem 61:697-703.
53. Peeper D, Van der Eb A, Zantema A (1994): The G1/S cell-cycle checkpoint in eucaryotic cells. Biochim Biophys Acta 1198:215-230.
54. Peter M, Herskowitz I (1994): Joining the complex: Cyclin dependent kinase inhibitory proteins and the cell cycle. Cell 79:181-184.
55. Poluha W, Poluha DK, Chang B, Crosbie NE, Schonhoff CM, Kilpatrick DL, Ross AH (1996): The cyclin-dependent kinase inhibitor p21WAF1 is required for survival of differentiating neuroblastoma cells. Mol Cell Biol 16:1335-1341.
56. Raffioni S, Bradshaw RA (1995): Staurosporine causes epidermal growth factor to induce differentiation in PC12 cells via receptor up-regulation. J Biol Chem 270:7568-7572.
57. Rasouly D, Lazarovici P (1994): Staurosporine induces tyrosine phosphorylation of a 145 kDa protein but does not activate gp140trk in PC12 cells. Eur J Pharmacol 269:255-264.
58. Reinhold DS, Neet KE (1989): The lack of a role for protein kinase C in neunte extension and in the induction of ornithine decarboxylase by nerve growth factor in PC12 cells. J Biol Chem 264:3538-3544.
59. Rudkin BB, Lazarovici P, Levi BZ, Abe Y, Fujita K, Guroff G (1989): Cell cycle-specific action of nerve growth factor in PC12 cells: Differentiation without proliferation. EMBO J 8:3319-3325.
60. Sako T, Tauber A, Jeng A, Yuspa S, Blumberg P (1988): Contrasting actions of staurosporine, a protein kinase C inhibitor, on human neutrophils and primary mouse epidermal cells. Cancer Res 48:4646-4650.
61. Shaulsky G, Goldfinger N, Ben-Ze'ev A, Rotter V (1990): Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis. Mol Cell Biol 10:6565-6577.
62. Shaulsky G, Goldfinger N, Peled A, Rotter V (1991): Involvement of wild type p53 in pre B cell differentiation in vivo. Proc Natl Acad Sci USA 88:8982-8986.
63. Shea T, Beerman M (1991): Staurosporine induced morphological differentiation of human neuroblastoma cells. Cell Biol Inter Report 15:161-168.
64. Sherr C (1994): G1 phase progression: Cycling on cue. Cell 79:551-562.
65. Solomon M (1994): The function(s) of CAK, the p34cdc2 activating kinase. TIBS 19:496-499.
66. Spitkovsky D, Steiner P, Gopalkrishnan RV, Eilers M, Jansen-Durr P (1995): The role of p53 in coordinated regulation of cyclin D1 and p21 gene expression by the adenovirus E1A and E1B oncogenes. Oncogene 10:2421-2425.
67. Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA, El-Houseini ME (1994): Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9:3389-3396.
68. Sturzbecher H-W, Maimets T, Chumakov P, Brain R, Addison C, Simanis V, Rudge K, Philp R, Grimaldi M, Court W, Jenkins JR (1990): p53 interacts with p34cdc2 in mammalian cells: implications for cell cycle control and oncogenesis. Oncogene 5:795-801.
69. Tamaoki T (1991): Use and specificity of staurosporine and calphostin C as protein kinase inhibitors. Methods Enzymol 201:340-345.
70. Teng KK, Greene LA (1993): Depolarization maintains neuntes and priming of PC12 cells after nerve growth factor withdrawal. J Neurosci 13:3124-3135.
71. Tsai L, Lees E, Faha B, Harlow E, Raibowol K (1993): The cdk2 kinase is required for the G1-S transition in mammalian cells. Oncogene 8:1593-1602.
72. Ullrich SJ, Anderson CW, Mercer WE, Appella E (1992): The p53 tumor suppressor protein, a modulator of cell proliferation. J Biol Chem 267:15259-15262.
73. Ullrich SJ, Sakaguchi KL, Mercer WE, Anderson CW, Apella E (1993): Phosphorylation at ser 15 and ser 392 in mutant p53 molecules from human tumors is altered compared to wild type p53. Proc Natl Acad Sci USA 90:5954-5958.
74. van Grunsven LA, Thomas A, Urdiales JL, Machenaud S, Choler P, Durand I, Rudkin BB (1996): Nerve growth factor-induced accumulation of PC12 cells expressing cyclin D1: Evidence for a G1 phase block. Oncogene 12:855-862.
75. Vogelstein B, Kinzler KW (1992): p53 function and disfunction. Cell 70:523-526.
76. Wang Y, Eckhart W (1992): Phosphorylation sites in the amino terminal region of mouse p53. Proc Natl Acad Sci USA 89:4231-4235.
77. Woodruff NR, Neet KE (1986): β-nerve growth factor binding to PC12 cells. Association kinetics and cooperative interactions. Biochemistry 25:7956-7966.
78. Yaglom J, Maarten H, Linskens K, Sadis S, Rubin DM, Futcher B, Finley D (1995): p34cdc28 mediated control of cln3 cyclin degradation. Mol Cell Biol 15:731-741.
79. Van GZ, Ziff EB (1995): NGF regulates the PC12 cell cycle machinery through specific inhibition of the Cdk kinases and induction of cyclin D1. J Neurosci 15:6200-6212.
80. Yewdell JW, Cannon JV, Lane DP (1986): Antibody analysis of p53 expression in normal and transformed cells. J Virology 59:444-452.
81. Young SW, Dickens M, Tavare JM (1994): Differentiation of PC12 cells in response to a cAMP analogue is accompanied by sustained activation of mitogen-activated protein kinase. Comparison with the effects of insulin, growth factors and phorbol esters. FEBS Lett 338:212-216.
82. Zauberman A, Lupo A, Oren M (1995): Identification of p53 target genes through immune selection of genomic DNA: The cyclin G gene contains two distinct p53 binding sites. Oncogene 10:2361-2366.
83. Zhou W, Takuna N, Kumada M, Takuna Y (1993): Protein kinase C mediated bidirectional regulation of DNA synthesis, Rb protein phosphorylation and cyclin-dependent kinases in human vascular endothelial cells. J Biol Chem 268:23041-23048.